3,4-dihydroxybenzylamine has been researched along with buthionine sulfoximine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| FitzGerald, GB; Prezioso, JA; Wick, MM | 1 |
| Blarzino, C; Cini, C; Coccia, R; De Marco, F; Di Domenico, F; Foppoli, C; Morici, S; Paolini, F; Perluigi, M | 1 |
2 other study(ies) available for 3,4-dihydroxybenzylamine and buthionine sulfoximine
| Article | Year |
|---|---|
Melanoma cytotoxicity of buthionine sulfoximine (BSO) alone and in combination with 3,4-dihydroxybenzylamine and melphalan.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Buthionine Sulfoximine; Dopamine; Glutathione Peroxidase; Humans; Hydrogen Peroxide; Melanoma; Melanoma, Experimental; Melphalan; Methionine Sulfoximine; Mice; Tumor Cells, Cultured | 1992 |
Expression of human papilloma virus type 16 E5 protein in amelanotic melanoma cells regulates endo-cellular pH and restores tyrosinase activity.
Topics: Antimetabolites, Antineoplastic; Buthionine Sulfoximine; Cell Line, Tumor; Dopamine; Endosomes; Enzyme Activation; Gene Expression; Humans; Hydrogen-Ion Concentration; Melanins; Melanoma, Amelanotic; Monophenol Monooxygenase; Oncogene Proteins, Viral; Proton Pump Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Skin Neoplasms; Transfection | 2009 |